Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 446: | Line 446: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous Hyperplasia''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous Hyperplasia''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 480: | Line 463: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Allergic Contact Dermatitis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Allergic Contact Dermatitis''' | ||
| style="background: #F5F5F5; padding: 5px;" |Itchy rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 492: | Line 477: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Not contagious | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Atopic Dermatitis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Atopic Dermatitis''' | ||
| style="background: #F5F5F5; padding: 5px;" |Itchy rash | |||
| style="background: #F5F5F5; padding: 5px;" |Fever | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red rash | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 508: | Line 494: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Chronic and sometimes accompanied by asthma | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Atypical Fibroxanthoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Atypical Fibroxanthoma''' | ||
Line 577: | Line 560: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Contains choristomatous tissue | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Benign congenital tumor | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis''' | ||
Line 616: | Line 599: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Fibrous xanthoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 631: | Line 612: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Containing fibromatous elements | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Arises due to disturbed systemic lipid metabolism | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflamed seborrheic keratosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflamed seborrheic keratosis''' | ||
Line 654: | Line 638: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Reddened, yellowish-tan color of lesions | |||
| style="background: #F5F5F5; padding: 5px;" |Slightly raised bumps | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 663: | Line 649: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Typically | ||
|} | |} |
Revision as of 20:22, 31 January 2019
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Cutaneous squamous cell carcinoma | pain | erythema | indurated | hyperkeratotic | increased size | skin biopsy |
| ||||||||
Merkel cell carcinoma | Starts on areas of skin exposed to the sun | Single pink, red, or purple shiny bump | Painless | Skin biopsy | blue-red, dome-shaped nodule | ||||||||||
Nodular malignant melanoma |
| ||||||||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | red, nonspecific lesion with slightly elevated borders | skin biopsy |
| ||||||||||
Basal cell carcinoma | Coarse scale lesion | ||||||||||||||
Superficial basal cell carcinoma | scaly patch | erythematous lesion |
|
skin biopsy | |||||||||||
Nodular basal cell carcinoma | Pearly papule with telangiectasias | Skin biopsy | |||||||||||||
Cutaneous metastases of internal malignancy | |||||||||||||||
Benign Skin Lesions | |||||||||||||||
Sebaceous cell carcinoma | |||||||||||||||
rhabdomyosarcoma | |||||||||||||||
Actinic keratoses | pain | hyperkeratosis | erythema | less pigmentation, and tend to be somewhat smaller in size. | Skin biopsy | ||||||||||
Prurigo nodules | Hard lesion | Itchy lumps | |||||||||||||
Paget disease | |||||||||||||||
Inflamed seborrheic keratosis | waxy, "stuck on," often hyperkeratotic appearance | On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | Skin biopsy | ||||||||||||
Viral warts | Verrucous lesion | Caused by HPV | |||||||||||||
Pyogenic granuloma | Rapidly growing | Red, dome-shaped | Friable papule with a collarette of scale | ||||||||||||
Bowenoid papulosis | multiple, red- to brown-colored, small papules that |
| |||||||||||||
Nummular eczema | Itchy lesions | Coin shaped spots | Chronic condition | ||||||||||||
Psoriasis | |||||||||||||||
Pyoderma gangrenosum | Purulent ulcer | Ragged and violaceous border | |||||||||||||
Venous stasis ulcers | |||||||||||||||
Traumatic ulcers | |||||||||||||||
Bowen Disease | |||||||||||||||
Sebaceous Hyperplasia | |||||||||||||||
Allergic Contact Dermatitis | Itchy rash | Red rash | Not contagious | ||||||||||||
Atopic Dermatitis | Itchy rash | Fever | Red rash | Chronic and sometimes accompanied by asthma | |||||||||||
Atypical Fibroxanthoma | Erythematous, dome-shaped papule | ||||||||||||||
Nevus | |||||||||||||||
Chemical Burns | |||||||||||||||
Limbal Dermoid | Contains choristomatous tissue | Benign congenital tumor | |||||||||||||
Benign hereditary intraepithelial dyskeratosis | |||||||||||||||
primary acquired melanosis | |||||||||||||||
Fibrous xanthoma | Containing fibromatous elements | Arises due to disturbed systemic lipid metabolism | |||||||||||||
Inflamed seborrheic keratosis | Inflamed and hyperpigmented | ||||||||||||||
Juvenile xanthogranuloma | Reddened, yellowish-tan color of lesions | Slightly raised bumps | Typically |